Given that CD4 + CD25 + Foxp3 + is the predominant Treg phenotype (Jang et al. 2019), we utilized hospital cohort breast cancer samples for IHC testing of CCL11, CD4, and Foxp3 proteins. This evidence concerns the gene CCL11 and breast cancer.